Fingerprint
Dive into the research topics of 'A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically